Published in Nat Genet on June 01, 2001
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature (2007) 5.65
Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19
Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28
Evolution of the cancer genome. Nat Rev Genet (2012) 3.24
Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell (2007) 3.23
Telomeres, stem cells, senescence, and cancer. J Clin Invest (2004) 2.87
Different telomere damage signaling pathways in human and mouse cells. EMBO J (2002) 2.87
The chromosomal instability pathway in colon cancer. Gastroenterology (2010) 2.59
Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer (2008) 2.54
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol (2002) 2.44
DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol (2012) 2.39
Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci U S A (2005) 2.11
Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A (2002) 2.03
Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell (2011) 1.99
Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell (2007) 1.96
Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92
Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell (2012) 1.91
The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev (2007) 1.88
Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet (2009) 1.86
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell (2012) 1.75
Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J (2002) 1.74
Resolution of anaphase bridges in cancer cells. Chromosoma (2004) 1.72
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J (2012) 1.71
Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell (2009) 1.67
Telomeres, chromosome instability and cancer. Nucleic Acids Res (2006) 1.67
Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity. Proc Natl Acad Sci U S A (2005) 1.61
DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia (2002) 1.47
Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. Blood (2014) 1.46
Chromosome instability as a result of double-strand breaks near telomeres in mouse embryonic stem cells. Mol Cell Biol (2002) 1.43
Telomere biology in healthy aging and disease. Pflugers Arch (2009) 1.41
DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol Cell Biol (2006) 1.39
Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging. EMBO J (2005) 1.38
Intrastrand annealing leads to the formation of a large DNA palindrome and determines the boundaries of genomic amplification in human cancer. Mol Cell Biol (2007) 1.36
Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer (2003) 1.34
p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet (2009) 1.33
Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol Cell Biol (2002) 1.32
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control (2009) 1.32
End resection initiates genomic instability in the absence of telomerase. Mol Cell Biol (2003) 1.32
APC and its modifiers in colon cancer. Adv Exp Med Biol (2009) 1.28
The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice. J Clin Invest (2011) 1.20
Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements. Nucleic Acids Res (2009) 1.19
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer (2007) 1.17
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. J Clin Invest (2002) 1.14
Telomere length is reset during early mammalian embryogenesis. Proc Natl Acad Sci U S A (2004) 1.14
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol (2013) 1.12
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer. Cell Stem Cell (2015) 1.11
Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer. Gut (2003) 1.09
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc Natl Acad Sci U S A (2007) 1.07
Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer (2002) 1.03
Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction. Nat Cell Biol (2011) 1.02
Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications. Ageing Res Rev (2008) 1.02
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol (2008) 1.02
The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia (2011) 1.00
Selective pressures for and against genetic instability in cancer: a time-dependent problem. J R Soc Interface (2008) 1.00
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol (2015) 0.99
Stabilization of dicentric translocations through secondary rearrangements mediated by multiple mechanisms in S. cerevisiae. PLoS One (2009) 0.98
Regulation of senescence in cancer and aging. J Aging Res (2011) 0.98
Telomere fusions in early human breast carcinoma. Proc Natl Acad Sci U S A (2012) 0.97
Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation. J Biol Chem (2010) 0.96
Isolation of chromatin from dysfunctional telomeres reveals an important role for Ring1b in NHEJ-mediated chromosome fusions. Cell Rep (2014) 0.95
Telomerase-dependent and -independent chromosome healing in mouse embryonic stem cells. DNA Repair (Amst) (2008) 0.95
Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. J Clin Invest (2012) 0.95
Important molecular genetic markers of colorectal cancer. Oncotarget (2016) 0.94
Stop pulling my strings - what telomeres taught us about the DNA damage response. Nat Rev Mol Cell Biol (2016) 0.93
The short and long telomere syndromes: paired paradigms for molecular medicine. Curr Opin Genet Dev (2015) 0.93
PinX1: a sought-after major tumor suppressor at human chromosome 8p23. Oncotarget (2011) 0.92
Telomere dynamics in mice and humans. Semin Hematol (2013) 0.92
Differences in telomerase activity between colon and rectal cancer. Can J Surg (2014) 0.92
The role of transgenic mouse models in carcinogen identification. Environ Health Perspect (2003) 0.91
Altered states of telomere deprotection and the two-stage mechanism of replicative aging. Mol Cell Biol (2009) 0.91
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet (2013) 0.91
Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor. Exp Mol Med (2010) 0.90
Modeling human endothelial cell transformation in vascular neoplasias. Dis Model Mech (2013) 0.89
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol (2010) 0.89
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med (2010) 0.87
Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression. Pigment Cell Melanoma Res (2011) 0.87
The role of dicentric chromosome formation and secondary centromere deletion in the evolution of myeloid malignancy. Genet Res Int (2011) 0.85
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat Commun (2015) 0.85
Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion. EMBO J (2015) 0.84
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer (2004) 0.84
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability. Cancer Discov (2017) 0.83
Complex roles for telomeres and telomerase in breast carcinogenesis. Breast Cancer Res (2002) 0.83
Cause-specific telomere factors deregulation in hepatocellular carcinoma. J Exp Clin Cancer Res (2013) 0.83
Therapeutic targeting of replicative immortality. Semin Cancer Biol (2015) 0.83
Sod2 haploinsufficiency does not accelerate aging of telomere dysfunctional mice. Aging (Albany NY) (2009) 0.83
Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis. Oncogene (2012) 0.82
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma. Neoplasia (2002) 0.82
The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity. Neoplasia (2014) 0.82
How do tumors make ends meet? Proc Natl Acad Sci U S A (2001) 0.82
A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes. Retrovirology (2005) 0.82
Worldwide genetic structure in 37 genes important in telomere biology. Heredity (Edinb) (2011) 0.81
The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice. Mol Carcinog (2009) 0.81
Telomeres in cancer: tumour suppression and genome instability. Nat Rev Mol Cell Biol (2017) 0.80
Cancer stem cells: relevance to clinical transplantation. Curr Opin Oncol (2012) 0.80
Fastest time to cancer by loss of tumor suppressor genes. Bull Math Biol (2014) 0.79
Cancer stem cells-clinical relevance. J Mol Med (Berl) (2009) 0.79
Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis. Cancer Biol Ther (2010) 0.78
Acacetin and chrysin, two polyphenolic compounds, alleviate telomeric position effect in human cells. Mol Ther Nucleic Acids (2013) 0.78
KLF4 Suppresses Tumor Formation in Genetic and Pharmacological Mouse Models of Colonic Tumorigenesis. Mol Cancer Res (2016) 0.77
Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation. Aging Cell (2016) 0.77
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell (1991) 9.54
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature (1997) 7.66
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (2000) 7.28
Essential role of mouse telomerase in highly proliferative organs. Nature (1998) 7.23
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell (1999) 6.98
Malignant glioma: genetics and biology of a grave matter. Genes Dev (2001) 6.78
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell (1999) 5.93
Cellular senescence: mitotic clock or culture shock? Cell (2000) 5.17
A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature (1986) 4.95
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature (2000) 4.75
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (1994) 4.52
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell (2000) 3.82
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2001) 3.69
An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell (1995) 3.68
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev (1998) 3.68
Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev (1986) 3.65
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev (2000) 3.62
The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev (1999) 3.50
Human N-myc is closely related in organization and nucleotide sequence to c-myc. Nature (1986) 3.40
The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A (2000) 3.21
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science (2000) 2.67
Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. EMBO J (1986) 2.62
Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene (1998) 2.49
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell (1999) 2.46
Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science (1995) 2.42
Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39
Structure and expression of the murine N-myc gene. Proc Natl Acad Sci U S A (1986) 2.36
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet (2000) 2.34
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene (1999) 2.34
Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene (1998) 2.27
Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet (2000) 2.19
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol (2001) 2.09
A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev (2000) 1.88
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev (2000) 1.87
Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell (2001) 1.85
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature (1998) 1.82
p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A (2001) 1.75
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A (1997) 1.74
p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci U S A (1998) 1.73
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev (1992) 1.68
Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell (2001) 1.68
Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67
Histogenesis of the so-called "intravascular bronchioloalveolar tumour". J Pathol (1979) 1.61
The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci (1998) 1.59
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A (1994) 1.56
Essential role for Max in early embryonic growth and development. Genes Dev (2000) 1.46
Repression by the Mad(Mxi1)-Sin3 complex. Bioessays (1998) 1.45
Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci U S A (1998) 1.41
Isolation of highly purified fractions of plasma membrane and tonoplast from the same homogenate of soybean hypocotyls by free-flow electrophoresis. Plant Physiol (1986) 1.39
Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. Proc Natl Acad Sci U S A (1997) 1.37
Expression and activity of L-Myc in normal mouse development. Mol Cell Biol (1996) 1.36
The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine (Baltimore) (1985) 1.35
Mice without telomerase: what can they teach us about human cancer? Nat Med (2000) 1.33
Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med (1995) 1.32
Tumors of ceruminous glands. Cancer (1972) 1.26
Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci U S A (1995) 1.26
Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells. Genetics (1997) 1.25
Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol (1994) 1.23
Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci (1999) 1.20
Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J Biol Chem (1992) 1.18
Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res (1999) 1.17
Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development (1999) 1.14
Myc and Max: a putative transcriptional complex in search of a cellular target. Curr Opin Cell Biol (1992) 1.13
Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs. Mol Cell Biol (1993) 1.07
Zebra fish myc family and max genes: differential expression and oncogenic activity throughout vertebrate evolution. Mol Cell Biol (1993) 1.07
Tetracycline-inducible system for photoreceptor-specific gene expression. Invest Ophthalmol Vis Sci (2000) 1.03
Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J (1995) 1.02
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin Cancer Biol (2001) 1.01
Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr Biol (2001) 1.01
Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci U S A (2001) 1.00
Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol Cell Biol (2001) 0.98
Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res (2001) 0.97
Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Oncogene (1996) 0.97
Animal models of melanoma: recent advances and future prospects. Adv Cancer Res (2000) 0.96
Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1. Oncogene (1994) 0.95
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol (2001) 0.93
Transcriptional repression. The cancer-chromatin connection. Nature (1998) 0.92
Role of first exon/intron sequences in the regulation of myc family oncogenic potency. Oncogene (1993) 0.89
Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet (2000) 0.89
Unlimited mileage from telomerase? Science (1999) 0.89
Structural and functional analysis of the mouse mdr1b gene promoter. J Biol Chem (1991) 0.88
The glucocorticoid hormone signal transduction pathway in mice homozygous for chromosomal deletions causing failure of cell type-specific inducible gene expression. Proc Natl Acad Sci U S A (1991) 0.87
Effect of transition metals on recovery from plasma of the growth-modulating tripeptide glycylhistidyllysine. J Chromatogr (1979) 0.87
Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol Cell Biol (1999) 0.87
Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver. Mol Cell Biol (1991) 0.87
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans. Gastroenterology (1984) 0.85
The interplay between nonhomologous end-joining and cell cycle checkpoint factors in development, genomic stability, and tumorigenesis. Cold Spring Harb Symp Quant Biol (2000) 0.85
Flipping the oncogene switch: illumination of tumor maintenance and regression. Trends Genet (2000) 0.84